Business · 13/07/2001Updated: 10/17/2026 · 1 min read
FDA Clears Cyclosporine Capsules for Approval
Summary
The Food and Drug Administration (FDA) has ruled that the 50mg version of Neoral Soft Gelatin Capsules was not removed from the market due to safety or efficacy concerns, paving the way for the approval of abbreviated new drug applications (ANDAs) for this formulation.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →